Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study.
Podlipnik S, Carrera C, Boada A, Richarz N, Marcoval J, Ferreres JR, Bodet D, Martí RM, Segura S, Sabat M, Dalmau J, Quintana M, Azon A, Curcó N, Formigon M, Olivella-Garcés MR, Zaballos P, Sola J, Galvany L, Baliu-Piqué C, Alegre M, Pasquali P, Malvehy J, Puig S, On Behalf Of The Network Of Melanoma Centres Of Catalonia. Podlipnik S, et al. Among authors: baliu pique c. J Clin Med. 2020 Oct 23;9(11):3396. doi: 10.3390/jcm9113396. J Clin Med. 2020. PMID: 33113930 Free PMC article.
Melanoma-specific survival is worse in the elderly: a multicentric cohort study.
Segura S, Podlipnik S, Boada A, Martí RM, Sabat M, Yélamos O, Zarzoso-Muñoz I, Azón-Masoliver A, López-Castillo D, Solà J, Baliu-Piqué C, Galvany-Rossell L, Pasquali P, Just-Sarobé M, Duran X, Carrera C, Richarz NA, Pujol RM, Malvehy J, Puig S; Network of Melanoma Centres of Catalonia. Segura S, et al. Among authors: baliu pique c. Melanoma Res. 2023 Dec 1;33(6):532-538. doi: 10.1097/CMR.0000000000000923. Epub 2023 Sep 4. Melanoma Res. 2023. PMID: 37696262
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
Melé-Ninot G, Serra-Baldrich E, Spertino J, Guilarte M, Ribó González P, Lleonart-Bellfill R, Figueras-Nart I, Bonfill-Ortí M, Depreux N, Sala-Cunill A, Bielsa-Marsol I, Baliu-Piqué C, Sanmartín-Novell V, Garcia-Navarro X, Expósito-Serrano V, Garnica-Velandia D, Diaz-Sarrió MC, Gómez-Armayones S, Gich Saladich I, Giménez-Arnau A. Melé-Ninot G, et al. Among authors: baliu pique c. Eur J Dermatol. 2022 Sep 1;32(5):629-631. doi: 10.1684/ejd.2022.4334. Eur J Dermatol. 2022. PMID: 36468733 English.
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gómez Armayones S, Serra-Baldrich E, Spertino J, Bonfill Ortí M, Figueras Nart I, Melé-Ninot G, Baliu-Piqué C, Sala Cunill A, Labrador-Horrillo M, Guilabert Vidal A, Fernández Chico N, Giménez-Arnau AM. Exposito-Serrano V, et al. Among authors: baliu pique c. Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2. Br J Dermatol. 2021. PMID: 32730636 No abstract available.
Nail-patella syndrome: report of 11 pediatric cases.
Figueroa-Silva O, Vicente A, Agudo A, Baliu-Piqué C, Gómez-Armayones S, Aldunce-Soto MJ, Inarejos Clemente EJ, Navallas Irujo M, Gutiérrez de la Iglesia D, González-Enseñat MA. Figueroa-Silva O, et al. J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1614-7. doi: 10.1111/jdv.13683. Epub 2016 Apr 25. J Eur Acad Dermatol Venereol. 2016. PMID: 27109743
Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab.
Spertino J, Curto Barredo L, Rozas Muñoz E, Figueras Nart I, Gimenez Arnau A, Serra Baldrich E, Bonfill-Ortí M, Expósito-Serrano V, Guilabert A, Melé Ninot G, Villar Buil M, Garcias Ladaria J, García Navarro X, Vilavella M, Bielsa Marsol I, Aparicio Ortiz G, Baliu Piqué C, Álvarez Abella A, Lamas Domenech N, Mascaró JM, Gómez S, Torné Gutiérrez JI, Vicente Villa A, Gimenez Arnau A. Spertino J, et al. Among authors: baliu pique c. Actas Dermosifiliogr (Engl Ed). 2018 Nov;109(9):771-776. doi: 10.1016/j.ad.2018.07.005. Epub 2018 Aug 11. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 30107875 English, Spanish.
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G, Cubiró X, Bonfill-Ortí M, Garcias-Ladaria J, Villar M, García-Navarro X, Bielsa-Marsol I, Vilavella M, Aparicio G, Baliu-Piqué C, Álvarez A, Lamas-Domenech N, Duran-Jordà X, Serra-Baldrich E, Giménez-Arnau A. Curto-Barredo L, et al. Among authors: baliu pique c. Br J Dermatol. 2018 Jul;179(1):210-212. doi: 10.1111/bjd.16379. Epub 2018 Apr 25. Br J Dermatol. 2018. PMID: 29368377 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 32205081
16 results